Company Description

There are nearly 1 million end-stage kidney patients in the US. Oli is building a better future for these patients by creating compact, portable, and intuitively operated dialysis systems. Oli's core technology is based on a novel sorbent that enables miniaturization and simplified operation. They plan to deploy their MVP in clinics to accelerate regulatory approval for in-home or on-the-go patient use.